search

Active clinical trials for "Obesity"

Results 3391-3400 of 3572

Obesity and the Initiation of Knee Osteoarthritis

Obesity

Healthy adults aged 20-60 of varying weights will participate in this minimally invasive study. There is one 4-hour appointment for which subjects are paid $120. The tests involve: 1 tube blood draw, 1 gait test (motion capture) and 1 MR of both knees.

Completed7 enrollment criteria

Gut Hormone Response, Appetite and Intestinal Transit Time in Good and Poor Weight Responders After...

Obesity

The aim of the study is to describe differences in meal-stimulated gut hormone response, appetite and intestinal transit time between good and poor responders 1-2 years after Gastric Bypass surgery for obesity.

Completed7 enrollment criteria

Defining an Obesity QTL on Chromosome 3q

Cardiovascular DiseasesHeart Diseases1 more

To investigate the genetic basis of obesity by fine mapping an obesity quantitative trail linkage (QTL) linked to chromosome 3q.

Completed1 enrollment criteria

Macrophage Infiltration in Human Adipose Tissue

ObesityDiabetes

Quantification of macrophage infiltration and characterization of macrophage phenotype in adipose tissue of 60 obese subjects and 20 non obese subjects

Completed10 enrollment criteria

Evolution of Dyspnea After Bariatric Surgery in Patient With Obesity

Obesity

Obesity, defined as a Body Mass Index greater than or equal to 30 kg/m2, represents a significant public health issue. Dyspnea is a very common and crippling symptom in obesity. About 80% of people with obesity experience dyspnea in daily living. Bariatric surgery has been demonstrated to be an excellent treatment for obesity by inducing significant weight loss. Nevertheless, changes in dyspnea in daily living after bariatric surgery and the links between variations in dyspnea and lung function tests after bariatric surgery have not been previously investigated.

Completed3 enrollment criteria

An Observational,Prospective Natural History Study of Early-Onset Extreme Obesity Due to Bi-Allelic...

POMC Deficiency ObesityPCSK1 Deficiency Obesity1 more

This is an observational study. There are no protocol-defined visits, although patients are expected to have routine office visits approximately every 6 months. Upon signing of informed consent/assent and study enrollment, historical data will be abstracted from the patient's medical chart. The patient will then be observed prospectively for up to 5 years, with additional data collected from routine healthcare encounters and direct-to-patient questionnaires (where local laws allow), including laboratory tests, physical exam and patient reported outcomes/quality of life measures. Patients will be consented/assented to provide blood samples for biomarker assessments, DNA sequencing and archiving.

Completed7 enrollment criteria

Laryngeal Mask in Morbid Obesity

Morbid Obesity

Investigators study the performance of both masks, Proseal Laryngeal Mask Airway (PLMA) and I-gel, as temporary ventilatory supraglottic airway devices (SGDs) before tracheal intubation in morbidly obese patients. Data are lacking in such population of patients

Unknown status2 enrollment criteria

BIO|STREAM.ICM Obesity

Tachycardia AtrialAtrial Fibrillation3 more

The aim of the submodule study is to assess whether a high BMI may influence the sensing performance and the sECG quality of the BIOMONITOR.

Completed3 enrollment criteria

Prevalence of Sarcopenia and Sarcopenic Obesity in Older Adults

SarcopeniaSarcopenic Obesity2 more

Syndromes such as sarcopenia, sarcopenic obesity and osteosarcopenic obesity are commonly seen in older adults. They result from the impairment of muscle, bone and adipose tissue. Thus, they lead to a decrease in quality of life and increase morbidity and mortality. The aim of this study is to report the prevalence of sarcopenia, sarcopenic obesity and osteosarcopenic obesity in community-dwelling outpatient older adults and to investigate the related factors.

Completed4 enrollment criteria

Sarcopenic Obesity Among Community Dwelling Elderly

Sarcopenic Obesity

Sarcopenic obesity (SO) is a geriatric syndrome, characterized by reduced muscle mass and function, and increase in body fat. It is classified as a new category of obesity in elderly. It found to be associated with higher risk of physical disability, hospitalization, metabolic syndrome, cardiovascular disorders and mortality. According to the United Nations Economic and Social Commission for Asia and The Pacific's (UNESCAP) 2016 population data, Malaysians aged sixty and above contribute to 9.5% of the population. The aging individuals are estimated to reach 23.5% of the population by 2050. In the matter of human health, SO increases the risk of falls and fracture, deteriorates the performance of activities of daily living, enhances the risk of getting multiple health-related outcomes and results in physical disability. Eventually, the quality of life is adversely affected. In financial terms, SO cause significant burden to health care systems. Both hospitalization and cost of care during hospitalization are increased. Therefore, study of SO has experienced a revitalized research interest due to its negative impact on public health. In addition, there is significant lack of literature related to prevalence of SO in community-dwelling elderly in Malaysia, hence, a need to investigate this phenomenon.

Completed10 enrollment criteria
1...339340341...358

Need Help? Contact our team!


We'll reach out to this number within 24 hrs